Enteral nutrition products cater to growing nutritional needs of people who cannot consume food orally or through normal diet. It provides vital nutrients to patients suffering from chronic diseases, cancer, neurological disorders and several other gastric complications. The enteral tubes provide easy access for delivering nutritional formulas containing proteins, carbohydrates, fat, vitamins and minerals directly into the stomach or small intestine. The global Enteral Nutrition Market is estimated to be valued at US$ 3.01 Bn in 2023 and is expected to exhibit a CAGR of 5.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The adoption of new technologies has accelerated growth in the enteral nutrition market. Technologies such as low-profile enteral tubes and portable enteral feeding pumps have improved comfort and mobility for patients. The automated bolus Feeding Programs and Feed Rate Memory functions in digital enteral feeding pumps prevent over- or under-feeding and maintain consistent nutrition delivery. The use of compact, lightweight enteral pumps helps improve mobility and independence for individuals requiring long-term enteral nutrition support at home. Rising focus on innovation and new product development are expected to drive the demand for enteral feeding devices and solutions during the forecast period.
Segment Analysis
The global enteral nutrition market is segmented by Protein composition into Standard Protein Diet, High Protein Supplement, Protein for Diabetic Patients, and Others. The standard protein diet segment dominates the market owing to ease of intake and balance in nutritional content. These products are cost effective and suitable for all age groups requiring nutrition supplements.
Key Takeaways
The global enteral nutrition market is expected to witness high growth over the forecast period of 2023 to 2030. The market is projected to grow at a CAGR of 5.8% during this period and reach a size of US$ 3.01 Bn by 2024.
Regional analysis: North America region currently dominates the global enteral nutrition market owing to high incidence of chronic diseases. The region is estimated to witness the fastest growth led by increasing healthcare expenditure and rising adoption of enteral nutrition products. Asia Pacific region is anticipated to emerge as the fastest growing market during the forecast period driven by growing geriatric population, improving access to healthcare facilities, and rising per capita income in nations such as China and India.
Key players: Key players operating in the enteral nutrition market are Abbott, Nestlé S.A., Danone S.A., Fresenius Kabi AG, Mead Johnson & Company, LLC, Braun Melsungen AG, Otsuka Pharmaceutical Co., Ltd, Meiji Holdings Co., Ltd. These players dominate the market due to their wide distribution channels and product portfolios offering comprehensive nutrition support.
No comments:
Post a Comment